MGY is expected to report higher revenues and an improved bottom line in the fourth quarter, driven by increased production and effective cost management.

LONDON--(BUSINESS WIRE)--Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, has officially launched its new puffer tote bag and sunglass collection. The puffer bag collection was inspired by the intuitive ‘throw in & go' approach to packing of Perfect Moment's president and chief creative officer, Jane Gottschalk. These versatile jumbo padded totes are the ultimate companion for life o.

Cisco Systems NASDAQ: CSCO latest earnings report exceeded analyst expectations, indicating a potential resurgence for the technology company. As a result, Cisco's stock price rose to new yearly highs, and investor confidence was seemingly renewed.

- KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA COVID-19 vaccines in clinical trials WALTHAM, Mass. and SAN DIEGO , Feb. 14, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European Commission has granted marketing authorization for KOSTAIVE ® (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for individuals 18 years and older.

Investing higher up in the capital structure of companies has its perks. Cumulative preferreds have demonstrated income resilience through serious headwinds and existential threats faced by issuers. We discuss our top preferred picks with well-covered dividends.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129493&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=129494&wire=1 or contact Joseph E. Levi, Esq.

KINSTON, N.C. & LAS VEGAS--(BUSINESS WIRE)--flyExclusive Inc. (NYSE American: FLYX), a publicly traded provider of premium jet charter experiences, has entered a definitive agreement to acquire the aviation business of Jet.AI Inc. (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company. flyExclusive will acquire the business in conjunction with Jet.AI's focus on being a pure-play AI solutions company. The transaction will occur following Jet.AI's spin of the business.

The Trade Desk's high valuation continues to create disappointment, despite the company's fundamentals remaining reasonably strong. The fourth quarter miss was attributed to execution issues, but it is not really clear what this means. While The Trade Desk has a strong business, it is maturing, meaning growth is likely to continue decelerating.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--New Data at ASCO GU Show Power of Veracyte's Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research.

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of metastatic uveal melanoma (mUM). Our proprietary products, HEPZATO KIT™ (HEPZATO (melphalan) for Injection/Hepatic Delivery System.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 million senior secured revolving credit facility with a bank syndicate. "Sarepta's financial strength and the positive outlook for our business provide us with the flexibility to use non-dilutive financing by establishing a revolving credit facility. It supplements our strong balance sheet and allows for contingent.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=129492&wire=1 or contact Joseph E. Levi, Esq.

TOKYO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE,” or the “Company”), a Japanese real estate developer of luxury residential properties including single-family homes, condominiums, and hotels, including its ENT TERRACE series in Tokyo and other properties in Kanagawa Prefecture, and Sapporo City, Japan, today announced that its ENT TERRACE ASAKUSA and ENT TERRACE AKIHABARA extended-stay hotels have received Booking.com's 13th Annual Traveler Review Awards 2025. This is the first time that ENT TERRACE ASAKUSA has received the award, while ENT TERRACE AKIHABARA has received the award for the second year in a row.

NEW YORK--(BUSINESS WIRE)--DDC Enterprise, Ltd. (NYSEAM: DDC), (“DayDayCook,” “DDC,” or the “Company”), a leading multi-brand Asian consumer food company, today announced that it has regained compliance with the New York Stock Exchange (“NYSE”) continued listing standards set forth in Part 10 of the NYSE American Company Guide. The Company has resolved the continued listing deficiency with respect to Section 1003(a)(i) referenced in a NYSE letter dated April 23, 2024. “We have made tremendous s.

CALGARY, AB , Feb. 14, 2025 /PRNewswire/ - Enbridge Inc. (TSX: ENB) (NYSE: ENB) has filed its Form 10-K for the year ended December 31, 2024, with the United States Securities and Exchange Commission. Enbridge has also filed its audited Consolidated Financial Statements and related Management's Discussion and Analysis for the year ended December 31, 2024, with Canadian securities regulatory authorities.

Chevron's (CVX 0.63%) shares are down just about 20% since hitting a peak in 2022. Brent Crude, a key oil benchmark, is down around 40% since 2022.

Proposed transaction provides flyExclusive with additional growth capital and will add trading liquidity through incremental equity ownership

OLD GREENWICH, Conn., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, announced today that its Board of Directors (the “Board”) declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is March 1, 2025, and the payment date is March 10, 2025.

Winter Park, FL, Feb. 14, 2025 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (Nasdaq: SRM) (the “Company,” or “SRM”), today announced a lock-up agreement with a major shareholder, Safety Shot, Inc., encompassing 2,347,142 shares of the Company's common stock. This represents approximately 13.7% of SRM Entertainment's outstanding shares. This agreement, effective as of February 10, 2025, restricts the shareholder from selling these shares until January 1, 2026, demonstrating a strong commitment to the Company's long-term vision and stability.